Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Healthcare
Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

Bullboard (TSX:NBLY)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Comment by BSdetector2016on Sep 01, 2023 4:23pm

RE:RE:Pretty much the all-time low

You have a bad actor in there - Losty. He's the supposed head of business development so why would he sell every time the SP has a bit of traction?
63
Discussion
Comment by Kanatainvestoron Sep 01, 2023 3:43pm

RE:Pretty much the all-time low

I wouldn't sweat it, fundamentally nothing has changed since this company raised at almost $30 in the spring of 2022. Interest rates have been rising for about 2 years, and the company is still ...more  
60
Discussion
Post by BSdetector2016on Sep 01, 2023 2:37pm

Pretty much the all-time low

Woof woof ! And a big thanks to you Steve Losty, VP Share Price Destruction.
89
Discussion
Post by Kanatainvestoron Sep 01, 2023 1:15pm

NBLY three levers of growth

NBLY three levers of EBITDA growth (M&A), organic business growth, and margin expansion provide for a solid outlook over the next couple of years. Using TD's mid-range M&A EBITDA ...more  
94
Post by retiredcfon Aug 31, 2023 10:50am

TD Report

Neighbourly Pharmacy Inc. (NBLY-T) C$15.48 Stress Testing the M&A Model Event In light of ongoing macroeconomic/industry headwinds, including elevated interest rates and ...more  
133
Post by BSdetector2016on Aug 31, 2023 8:46am

Losty is a serial share dumper II

He dumped a further 2,806 shares on August 10th, near the August SP peak.  His common share balance is ZERO. This twit does nothing for confidence in the company and the stock.
97
Post by BSdetector2016on Aug 31, 2023 7:39am

TD report on the basket case

After doing stress tests sees NBLY unlikely to trip its covenant over the next five years, and keeps its $28 target.
90
Post by Kanatainvestoron Aug 24, 2023 11:26am

Expanded Scope of Practice: Tailwind for Metro & Loblaws

Both Metro and Loblaws reported strong pharmacy performance last quarter, and pointed to pharamcy expanded scope of practice as a contributor to the results: Loblaws (Shoppers) earning call comments ...more  
109
Comment by Kanatainvestoron Aug 22, 2023 12:38pm

RE:Neighbourly is a basket case

This was due to a mere 200 shares trade. For the most part NBLY trade by appointment. This lack of liquidity tend to cause big swings in the stock price. If the volume continues to lag, and the stock ...more  
79
Discussion
Post by BSdetector2016on Aug 22, 2023 9:43am

Neighbourly is a basket case

Trading at $15.54. Analysts have a $23.50 consensus; are they delusional or what?
67
Discussion
Post by Kanatainvestoron Aug 16, 2023 10:11am

Maritime provinces expanding pharmacies scope of practice

Free consultations, expanded scope filling gaps in primary care, P.E.I. pharmacists say Ten months after launching, P.E.I. pharmacists say a provincial program funding consultations for common ...more  
116
Post by Kanatainvestoron Aug 14, 2023 2:06pm

Low volume sell off ...

On July 24th and 25th NBLY had a major reversal on a very high volume (compared to the average daily volume). And on August 1st, the stock rallied sharply after earnings on high volume as well. Today, ...more  
149
Post by retiredcfon Aug 07, 2023 9:53am

Another View

EPS of $0.11 beat estimates of $0.06; revenue of $196.8M marginally beat estimates. Same store growth was decent at 4.1% and EBITDA rose 77%. Sales rose 72%, with most of this (95%) from acquisitions. ...more  
108
Post by retiredcfon Aug 02, 2023 9:35am

TD

Neighbourly Pharmacy Inc. (NBLY-T) C$17.68 Making Progress on Several Fronts Event We are still very much positive on the margin recovery, but after reviewing our model ...more  
108
Post by Kanatainvestoron Aug 02, 2023 9:29am

NBLY shoudn't trade under $20

Having listened to the CC and fully digested the earnings release. I feel that the management team is executing exactly as planned as they transition from growth at all costs, to profitable growth at ...more  
102
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities